AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 289: F544-F551, 2005. First published April 12, 2005; doi:10.1152/ajprenal.00088.2005
0363-6127/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/3/F544    most recent
00088.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Haan, J. B.
Right arrow Articles by Tesch, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Haan, J. B.
Right arrow Articles by Tesch, G. H.

Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy

Judy B. de Haan,1 Nada Stefanovic,1 David Nikolic-Paterson,2 Lyndee L. Scurr,3 Kevin D. Croft,4 Trevor A. Mori,4 Paul Hertzog,1 Ismail Kola,5 Robert C. Atkins,2 and Gregory H. Tesch2

1Centre for Functional Genomics and Human Disease, Monash Institute of Reproduction and Development, Monash University, Victoria; 2Department of Nephrology and Monash University Department of Medicine, Monash Medical Centre, Victoria; 3Department of Gynaecological Oncology and Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, New South Wales; 4School of Medicine and Pharmacology, University of Western Australia, Australia; and 5Merck Research Laboratories, Rahway, New Jersey

Submitted 4 March 2005 ; accepted in final form 6 April 2005

In many diseases, including progressive renal disorders, tissue injury and pathological intracellular signaling events are dependent on oxidative stress. Glutathione peroxidase-1 (Gpx1) is an antioxidant enzyme that is highly expressed in the kidney and removes peroxides and peroxynitrite that can cause renal damage. Therefore, we examined whether this abundant renal antioxidant enzyme limits renal damage during the development of type 1 diabetic nephropathy. Wild-type (Gpx1+/+) and deficient (Gpx1–/–) mice were made diabetic by intraperitoneal injection of streptozotocin (100 mg/kg) on 2 consecutive days. Diabetic Gpx1+/+ and –/– mice with equivalent blood glucose levels (23 ± 4 mM) were selected and examined after 4 mo of diabetes. Compared with normal mice, diabetic Gpx1+/+ and –/– mice had a two- to threefold increase in urine albumin excretion at 2 and 4 mo of diabetes. At 4 mo, diabetic Gpx1+/+ and –/– mice had equivalent levels of oxidative renal injury (increased kidney reactive oxygen species, kidney lipid peroxidation, urine isoprostanes, kidney deposition of advanced glycoxidation, and nitrosylation end products) and a similar degree of glomerular damage (hypertrophy, hypercellularity, sclerosis), tubular injury (apoptosis and vimentin expression), and renal fibrosis (myofibroblasts, collagen, TGF-{beta} excretion). A lack of Gpx1 was not compensated for by increased levels of catalase or other Gpx isoforms in diabetic kidneys. Contrary to expectations, this study showed that the high level of Gpx1 expressed in the kidney is not protective against the development of renal oxidative stress and nephropathy in a model of type 1 diabetes.

gene deficiency; oxidative stress; renal injury



Address for reprint requests and other correspondence: G. Tesch, Dept. of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia (e-mail: gtesch{at}hotmail.com)




This article has been cited by other articles:


Home page
DiabetesHome page
J. M. Forbes, M. T. Coughlan, and M. E. Cooper
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Diabetes, June 1, 2008; 57(6): 1446 - 1454.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M.-L. Brezniceanu, F. Liu, C.-C. Wei, I. Chenier, N. Godin, S.-L. Zhang, J. G. Filep, J. R. Ingelfinger, and J. S.D. Chan
Attenuation of Interstitial Fibrosis and Tubular Apoptosis in db/db Transgenic Mice Overexpressing Catalase in Renal Proximal Tubular Cells
Diabetes, February 1, 2008; 57(2): 451 - 459.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Liu, M.-L. Brezniceanu, C.-C. Wei, I. Chenier, S. Sachetelli, S.-L. Zhang, J. G. Filep, J. R. Ingelfinger, and J. S.D. Chan
Overexpression of Angiotensinogen Increases Tubular Apoptosis in Diabetes
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 269 - 280.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.